Page last updated: 2024-08-25

dehydroleucodine and B16 Melanoma

dehydroleucodine has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbieri, MA; Costantino, VV; Cuello-Carrión, FD; Fernandez, D; Ibañez, J; Jahn, GA; Lobos-Gonzalez, L; Lopez, LA; Quest, AF; Semino, SN; Valenzuela, MA	1

Other Studies

1 other study(ies) available for dehydroleucodine and B16 Melanoma

Article	Year
Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis. Cancer letters, 2016, Mar-01, Volume: 372, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin B1; Cyclin D1; Dose-Response Relationship, Drug; Female; Inhibitor of Apoptosis Proteins; Lactones; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Models, Biological; Repressor Proteins; Sesquiterpenes; Signal Transduction; Survivin; Time Factors; Tumor Burden	2016

Article

Year

Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis.

Cancer letters, 2016, Mar-01, Volume: 372, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclin B1; Cyclin D1; Dose-Response Relationship, Drug; Female; Inhibitor of Apoptosis Proteins; Lactones; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Models, Biological; Repressor Proteins; Sesquiterpenes; Signal Transduction; Survivin; Time Factors; Tumor Burden

2016